Abstract
Introduction: Current evidence suggests that prior prostatic interventions, such as prostatectomy, radiation, or transurethral surgery, may increase the risk of incontinence in patients undergoing radical cystectomy (RC) with ileal orthotopic neobladder reconstruction. We aimed to evaluate the short- and long-term complications, functional outcomes of neobladder reconstruction in patients undergoing RC after prior prostatic procedures. Methods: We analyzed patients who underwent RC after prior prostatic intervention in our department from 2013 to 2022. A comparison was made between patients receiving neobladder reconstruction (ONB) versus ileal conduit, including propensity score matching for age and preoperative continence. Results: We included 79 patients who underwent RC for bladder cancer after prior prostatic intervention. Of them, 43 (54%) patients had previously undergone BPH surgery, 29 (37%) radical prostatectomy, and 7 (9%) prostate radiation therapy. An ileal conduit was performed in 62 (78%) cases. Patients presented similar baseline characteristics, perioperative complications, and quality of life after RC. Accordingly, after propensity-score-matching patients with ONB after prior prostatic intervention and patients who received ONB without prior prostatic intervention did not differ significantly in their baseline characteristics, perioperative complications, and quality of life. Overall, 24% of patients without prior intervention reported incontinence, compared to 53% with prior prostatic intervention. Conclusion: Neobladder reconstruction remains to be a feasible option in patients undergoing RC after prior prostatic intervention.
Journal Section:
Research Article
References
1.
Siegel
RL
, Miller
KD
, Jemal
A
. Cancer statistics, 2020
. CA Cancer J Clin
. 2020
;70
(1
):7
–30
. 2.
Morton
A
, Williams
M
, Perera
M
, Teloken
PE
, Donato
P
, Ranasinghe
S
, et al. Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data
. BJU Int
. 2020
;126
(Suppl 1
):18
–26
. 3.
Miotto
A
, Dall’Oglio
M
, Srougi
M
. Cystectomy with orthotopic reconstruction following radical retropubic prostatectomy
. Int Braz J Urol
. 2004
;30
(2
):125
–7
. 4.
Savvides
E
, Pyrgidis
N
, Langas
G
, Symeonidis
EN
, Dimitriadis
G
, Sountoulides
P
. Concomitant endoscopic surgery for bladder tumors and prostatic obstruction: are we safely hitting two birds with one stone? A systematic review and meta-analysis
. J Clin Med
. 2022
;11
(20
):6208
. 5.
Schuster
TG
, Marcovich
R
, Sheffield
J
, Montie
JE
, Lee
CT
. Radical cystectomy for bladder cancer after definitive prostate cancer treatment
. Urology
. 2003
;61
(2
):342
–7
. 6.
Vassantachart
A
, Daneshmand
S
, Cai
J
, Miranda
G
, Ghodoussipour
S
, Schuckman
AK
, et al. Feasibility and outcomes of orthotopic ileal neobladder reconstruction following pelvic irradiation
. Urology
. 2021
;148
:198
–202
. 7.
Kurokawa
G
, Sasaki
H
, Shimada
H
, Kasai
K
, Kimura
T
, Satou
S
, et al. Laparoscopic radical cystectomy with ileal neobladder for metachronous bladder cancer following laparoscopic radical prostatectomy: a case report]
. Hinyokika Kiyo
. 2022
;68
(3
):87
–90
. 8.
Huang
EY-H
, Skinner
EC
, Boyd
SD
, Cai
J
, Miranda
G
, Daneshmand
S
. Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy
. World J Urol
. 2012
;30
(6
):741
–5
. 9.
Hautmann
RE
, de Petriconi
RC
, Volkmer
BG
. 25 years of experience with 1,000 neobladders: long-term complications
. J Urol
. 2011
;185
(6
):2207
–12
. 10.
Pyrgidis
N
, Schulz
GB
, Ebner
B
, Jokisch
F
, Eismann
L
, Karatas
D
, et al. Radical cystectomy with ileal orthotopic neobladder after 70 Years leads to worse health-related quality of life
. J Clin Med
. 2024
;13
(20
):6102
. 11.
Aaronson
NK
, Ahmedzai
S
, Bergman
B
, Bullinger
M
, Cull
A
, Duez
NJ
, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
. J Natl Cancer Inst
. 1993
;85
(5
):365
–76
. 12.
Giannarini
G
, Kessler
TM
, Thoeny
HC
, Nguyen
DP
, Meissner
C
, Studer
UE
. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution
. Eur Urol
. 2010
;58
(4
):486
–94
. 13.
Kretschmer
A
, Grimm
T
, Buchner
A
, Grimm
J
, Grabbert
M
, Jokisch
F
, et al. Prognostic features for objectively defined urinary continence after radical cystectomy and ileal orthotopic neobladder in a contemporary cohort
. J Urol
. 2017
;197
(1
):210
–5
. 14.
Ali
AS
, Hayes
MC
, Birch
B
, Dudderidge
T
, Somani
BK
. Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion
. Eur J Surg Oncol
. 2015
;41
(3
):295
–9
. 15.
Grimm
T
, Grimm
J
, Buchner
A
, Schulz
G
, Jokisch
F
, Stief
CG
, et al. Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes
. World J Urol
. 2019
;37
(11
):2385
–92
. 16.
Zahran
MH
, El-Hefnawy
AS
, Zidan
EM
, El-Bilsha
MA
, Taha
DE
, Ali-El-Dein
B
. Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status
. Int J Urol
. 2014
;21
(9
):887
–92
. 17.
Bahlburg
H
, Tully
KH
, Bach
P
, Butea-Bocu
MC
, Reike
M
, Roghmann
F
, et al. Improvements in urinary symptoms, health-related quality of life, and psychosocial distress in the early recovery period after radical cystectomy and urinary diversion in 842 German bladder cancer patients: data from uro-oncological rehabilitation
. World J Urol
. 2024
;42
(1
):111
. 18.
Pyrgidis
N
, Schulz
GB
, Volz
Y
, Ebner
B
, Rodler
S
, Westhofen
T
, et al. The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study
. World J Urol
. 2024
;42
(1
):164
. 19.
Pyrgidis
N
, Volz
Y
, Ebner
B
, Kazmierczak
PM
, Enzinger
B
, Hermans
J
, et al. The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data
. World J Urol
. 2024
;42
(1
):19
. 20.
Pyrgidis
N
, Sokolakis
I
, Haltmair
G
, Hatzichristodoulou
G
. The effect of urinary diversion on renal function after cystectomy for bladder cancer: comparison between ileal conduit, orthotopic ileal neobladder, and heterotopic ileocecal pouch
. World J Urol
. 2022
;40
(12
):3091
–7
. 21.
Pyrgidis
N
, Sokolakis
I
, Haltmair
G
, Hatzichristodoulou
G
. The short- and long-term effect of radical cystectomy in frail patients with bladder cancer
. Clin Genitourin Cancer
. 2023
;21
(4
):e291
–8
. 22.
Kretschmer
A
, Mazzone
E
, Barletta
F
, Leni
R
, Heidegger
I
, Tsaur
I
, et al. Initial experience with radical prostatectomy following holmium laser enucleation of the prostate
. Eur Urol Focus
. 2021
;7
(6
):1247
–53
. 23.
Rosiello
G
, Piazza
P
, Tames
V
, Farinha
R
, Paludo
A
, Puliatti
S
, et al. The impact of previous prostate surgery on surgical outcomes for patients treated with robot-assisted radical cystectomy for bladder cancer
. Eur Urol
. 2021
;80
(3
):358
–65
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
